GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Medical System Holdings Ltd (OTCPK:CHSYF) » Definitions » Future Policy Benefits

China Medical System Holdings (China Medical System Holdings) Future Policy Benefits


View and export this data going back to 2013. Start your Free Trial

What is China Medical System Holdings Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


China Medical System Holdings (China Medical System Holdings) Business Description

Traded in Other Exchanges
Address
510 King’s Road, Unit 2106, 21st Floor, North Point, Island Place Tower, Hong Kong, HKG
China Medical System Holdings Ltd is active in the healthcare segment. It is one of the leading China-based pharmaceutical services companies in the country. The company's business mainly involves the marketing, promotion, and sales of prescription pharmaceutical products manufactured by domestic pharmaceutical companies. Some of its products include Plendil; Salofalk; Combizym; Ganfule Capsules; Xidakang; Hirudoid; and others. Geographically, it derives revenue from China.